Seer, Inc. (SEER) News
Track canonical SquawkNews coverage tagged to SEER, Seer, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 16 indexed stories across 10 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Seer Q2 EPS $(0.31) Misses $(0.27) Estimate, Sales $3.100M Miss $3.550M Estimate
Seer (NASDAQ: SEER ) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.27) by 14.81 percent. This is a 6.06 percent increase over losses of $(0.33) per share from the same
EARNINGS | Aug 11, 2026, 08:08 PM UTC
L
Seer Affirms FY2026 Sales Guidance of $16.000M-$18.000M vs $16.250M Est
Seer (NASDAQ: SEER ) affirms FY2026 sales outlook from $16.000 million-$18.000 million to $16.000 million-$18.000 million vs $16.250 million estimate.
EARNINGS | Aug 11, 2026, 08:06 PM UTC
L
SEER - Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
SEER - Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
EARNINGS | Aug 11, 2026, 08:06 PM UTC
L
SEER - Seer to Report Second Quarter 2026 Financial Results on August 11, 2026
SEER - Seer to Report Second Quarter 2026 Financial Results on August 11, 2026
EARNINGS | Aug 03, 2026, 08:06 PM UTC
L
SEER - Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D. -On Ju
SEER - Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D. -On July 29, 2026, Seer received a revised, unsolicited, non-binding acquisition propo
MNA | Jul 30, 2026, 09:35 PM UTC
H
SEER Receives Revised Acquisition Proposals
SEER receives revised acquisition proposals
MNA | Jul 30, 2026, 09:30 PM UTC
L
Seer Stockholders Re-Elect Directors
Seer stockholders re-elect all director nominees
EQUITY | Jul 28, 2026, 09:40 PM UTC
L
SEER Seer board rejects CEO's $2.45-per-share buyout offer
SEER Seer board rejects CEO's $2.45-per-share buyout offer
EQUITY | Jul 20, 2026, 10:27 AM UTC
L
SEER radoff-jec group - iss recommends voting for radoff-jec nominees berman and rinaldini, against nol pill at Seer Agm - Iss recommends wi
SEER radoff-jec group - iss recommends voting for radoff-jec nominees berman and rinaldini, against nol pill at Seer Agm - Iss recommends withholding support from terrance mcguire, dipchand nishar, nicolas roelofs at See
EQUITY | Jul 17, 2026, 12:23 PM UTC
L
Radoff-JEC Group Agrees With Seer CEO That It Should Not Be A Public Company; Advocates For Sale
Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group" or "we"), who collectively own approximately 7.7% of the outstanding common stock of Seer, Inc. (NASDAQ: SEER ) ("See
MNA | Jul 06, 2026, 12:08 PM UTC
L
Why Maison Solutions Shares Are Trading Higher By Over 62%; Here Are 20 Stocks Moving Premarket
Shares of Maison Solutions Inc (NASDAQ: MSS ) rose sharply in pre-market trading. Maison Solutions entered into an agreement to divest San Gabriel and Monrovia Store operations for $4.5 million as a part of strategic rea
MNA | Jul 06, 2026, 08:45 AM UTC
L
Seer Receives Unsolicited Acquisition Proposal From CEO Omid Farokhzad
() -- Seer (SEER) said late Thursday it has received an unsolicited, non-binding proposal from Omid Farokhzad, its chair and chief executive officer, to acquire all outstanding class A shares for $2.45 per share in cash
MNA | Jul 02, 2026, 09:19 PM UTC
L
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Seer (NASDAQ: SEER ) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals (NASDAQ: UPC ) stock m
EQUITY | Jul 02, 2026, 09:05 PM UTC
L
Seer Receives An Unsolicited, Non-Binding Proposal From Omid Farokhzad, M.D., Seer’s Chair And Chief Executive Officer, To Acquire All Of Th
Seer, Inc. (NASDAQ: SEER ), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding proposal from Omid Farokhzad, M.D., Seer’s Chair and Chi
MNA | Jul 02, 2026, 09:01 PM UTC
L
Seer Secures European Patent, U.S. International Trade Commission Probe Launched Into Alleged Nanomics Infringement
Seer, Inc. (NASDAQ: SEER ), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced two significant developments that reinforce the strength of the intellectual property portfolio protecting
EQUITY | Jul 01, 2026, 11:07 AM UTC
M
SEER Presents AI-Driven Plasma Proteomics
Seer and Korea University present preliminary data on AI-driven plasma proteomics for multi-cancer screening
EQUITY | Jun 22, 2026, 11:02 AM UTC